Patents by Inventor Patrizio Ferrari

Patrizio Ferrari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bifidobacteria and preparations containing them
    Patent number: 6960341
    Abstract: The disclosure refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.
    Type: Grant
    Filed: July 17, 2003
    Date of Patent: November 1, 2005
    Assignee: Alfa Wassermann S.p.A.
    Inventors: Claudio Giuseppe Viscomi, Leone Gabriele Rotini, Lorenzo Morelli, Patrizio Ferrari, Maria Rosaria Pantaleo
  • Bifidobacteria and preparations containing them
    Publication number: 20040047850
    Abstract: The present invention refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587, to their use as probiotics within preparations of pharmaceutical or alimentary type and to the preparations of pharmaceutical or alimentary type containing them useful to help the gastrointestinal health and to prevent and treat the intestinal pathologies.
    Type: Application
    Filed: July 17, 2003
    Publication date: March 11, 2004
    Applicant: ALFA WASSERMANN S.P.A.
    Inventors: Claudio Giuseppe Viscomi, Leone Gabriele Rotini, Lorenzo Morelli, Patrizio Ferrari, Maria Rosaria Pantaleo
  • Use of rifaximin and of pharmaceutical compositions containing it in the treatment of the diarrhoea from cryptosporidiosis
    Patent number: 5886002
    Abstract: The use of therapeutically effective amounts of rifaxmin and of pharmaceutical compositions containing it in the treatment of the diarrhoeal symptomatology in case of cryptosporidiosis in patients suffering from severe forms of immunodepression, for instance patients suffering from AIDS or malignant neoplasias, or subjected to transplantations or treated with chemotherapeutic or immunosuppressive agents is the object of the present invention.
    Type: Grant
    Filed: January 26, 1998
    Date of Patent: March 23, 1999
    Assignee: Alfa Wassermann S.p.A.
    Inventors: Patrizio Ferrari, Antonella Ferrieri, Pietro Caramello